This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An MRI-based radiomics model shows potential for distinguishing low- from high-risk cases of ductal carcinoma in situ (DCIS), an early form of breast cancer, according to a study published April 1 in Radiology. The study highlights how radiomics can help stratify risk in DCIS cases compared with clinical and qualitative imaging information alone, noted lead authors Kalina Slavkova, PhD, of Columbia University in New York City, and Ruya Kang, PhD, of Brown University in Providence, RI.
ORLANDO -- Point-of-care ultrasound (POCUS) residency tracks lead to marked improvement in exam performance by family medicine specialists, according to findings presented March 31 at the 2025 American Institute of Ultrasound in Medicine (AIUM) annual conference. In her talk, Laurel Gutierrez, MD, from the University of Michigan in Ann Arbor, discussed her teams research on how first-year residents significantly performed better on POCUS exams than non-track residents at their institution.
The Chicago-based manufacturer is buying the remaining stake in Nihon Medi-Physics, a Japanese developer of imaging agents used in SPECT and PET exams.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Radiopharmaceutical biotech firm Isotope Technologies Munich (ITM) has appointed Celine Wilke, MD, as its chief medical officer. In a statement, the company said that Wilke will lead the clinical development and medical teams in bringing ITM-11, ITMs targeted radionuclide therapy agent for neuroendocrine tumors, toward potential market approval, as well as further accelerating the development of other radiopharmaceuticals in the companys precision oncology pipeline.
Functional MRI (fMRI) is further revealing changes in the brain caused by repetitive blast exposure and highlights the need to rethink "mild" brain injuries across society, according to research published April 1 in Radiology. A team led by neuroradiologist Andrea Diociasi, MD, from Mass General Brigham in Boston studied 220 U.S. military special operations forces members and found that when standard MRI exams appeared normal, resting-state fMRI maps obtained from functional connectivity (FC) mu
The past decade has seen a major drive to get more people into STEM careers. The main challenge in expanding the STEM workforce isn’t a lack of interest; it’s the way STEM is portrayed. Many people see it as an exclusive field, accessible only to a select few. But in reality, STEM is all around us, embedded in almost every job and industry.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New multicenter research suggests that radiomic features derived from breast MRI may enhance prognostic capabilities with disease upstaging for ductal carcinoma in situ (DCIS).
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Todays customers have more options than ever. If they need a product or service, theres a good chance multiple businesses can provide what they seek. In addition, they know how to research. Online reviews and rankings help narrow down the options until they find a provider they’re happy with. Its no wonder lists of features and benefits don’t often sway the enlightened customer of today.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
261 
Let's personalize your content